Cite
HARVARD Citation
Buonamici, S. et al. (n.d.). Characterization of Novel Oral Splicing Modulator, H3B-8800, Identifies the Mechanistic Basis for its Preferential Lethality Towards Spliceosome-Mutant Myeloid Malignancy Models. Leukemia research. pp. S11-. [Online].